Readystate Asset Management »

Kalvista Pharmaceuticals shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 180k 11.58

More positions owned by Readystate Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Granite Constr Note 3.750% 5/1 (Principal)
Transmedics Group Note 1.500% 6/0 (Principal)
Hess (HES)
Freshpet Note 3.000% 4/0 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Workiva Note 1.250% 8/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
Impinj Note 1.125% 5/1 (Principal)
Walt Disney Company (DIS)
Alphabet Cap Stk Cl C (GOOG)
Dayforce Note 0.250% 3/1 (Principal)
NVIDIA Corporation Call Option (NVDA)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Suvretta Capital Management
Tang Capital Management
Frazier Life Sciences Management
Vestal Point Capital
Capital World Investors
BlackRock
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Boxer Capital Management
State Street Corporation
Octagon Capital Advisors
Woodline Partners
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals